Controversies in the treatment of early-stage Hodgkin's lymphoma
- PMID: 25901431
- DOI: 10.1056/NEJMe1502888
Controversies in the treatment of early-stage Hodgkin's lymphoma
Comment on
-
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.N Engl J Med. 2015 Apr 23;372(17):1598-607. doi: 10.1056/NEJMoa1408648. N Engl J Med. 2015. PMID: 25901426 Clinical Trial.
Similar articles
-
Chemotherapy alone for early-stage Hodgkin's lymphoma.N Engl J Med. 2012 Feb 2;366(5):470-1. doi: 10.1056/NEJMe1113291. Epub 2011 Dec 11. N Engl J Med. 2012. PMID: 22149920 No abstract available.
-
Chemotherapy alone for early Hodgkin's lymphoma: an emerging option.J Clin Oncol. 2005 Jul 20;23(21):4574-6. doi: 10.1200/JCO.2005.01.911. Epub 2005 Apr 18. J Clin Oncol. 2005. PMID: 15837972 No abstract available.
-
[Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].Clin Ter. 2001 May-Jun;152(3):203-6. Clin Ter. 2001. PMID: 11692542 Italian. No abstract available.
-
Combined modality treatment of Hodgkin's lymphoma.Cancer J. 2009 Mar-Apr;15(2):143-9. doi: 10.1097/PPO.0b013e31819e31ba. Cancer J. 2009. PMID: 19390310 Review.
-
Advanced Hodgkin's disease: ABVD is better, yet is not good enough!J Clin Oncol. 2003 Feb 15;21(4):583-5. doi: 10.1200/JCO.2003.11.072. J Clin Oncol. 2003. PMID: 12586791 Review. No abstract available.
Cited by
-
Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.Curr Treat Options Oncol. 2015 Sep;16(9):45. doi: 10.1007/s11864-015-0360-6. Curr Treat Options Oncol. 2015. PMID: 26187795 Review.
-
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML).Leuk Res. 2016 Sep;48:92-100. doi: 10.1016/j.leukres.2016.07.004. Epub 2016 Jul 25. Leuk Res. 2016. PMID: 27544076 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical